Molecular markers for colorectal cancer screening | Gut
PLOS ONE: CCR6 Is a Prognostic Marker for Overall Survival in Patients with Colorectal Cancer, and Its Overexpression Enhances Metastasis In Vivo
Biochemical Markers of Colorectal Cancer – Present and Future | CMAR
Expression of ICAM-1 in human colon cancer. (a) Immunohistochemical... | Download Scientific Diagram
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series - The Lancet Gastroenterology &
Frontiers | Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research | Oncology
Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review)
Inhibition of AR prevents expression of metastatic markers during colon... | Download Scientific Diagram
Molecular Markers for Colorectal Cancer - Surgical Clinics
Table 1 from Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy | Semantic Scholar
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
PLOS ONE: CCR6 Is a Prognostic Marker for Overall Survival in Patients with Colorectal Cancer, and Its Overexpression Enhances Metastasis In Vivo
Differences regarding tumor marker expression between synchronous and... | Download Table
Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer - ScienceDirect
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup | Oncology
Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer.,Scientific Reports - X-MOL
Supplemental Materials for Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy - Radiotherapy and Oncology
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study - Annals of Oncology
Understanding The CEA Test in Colon Cancer - CancerConnect
Apatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study | Scientific Reports
JCI - Is CD133 a marker of metastatic colon cancer stem cells?
Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1 - Clinical Colorectal Cancer
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array
Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies - EBioMedicine
